Omnicell OMCL
NASDAQ OMCL
$37.85 +0.51 (+1.38%)
As of: Nov 9, 2026 · 10:10 AM EST

Omnicell (OMCL) Net Income towards Common Stockholders (2010 - 2026)

Updated

Omnicell (OMCL) recorded Net Income towards Common Stockholders of $11.04 million in Q3 2026, up 102.2% from $5.46 million a year earlier but down 54.5% from the prior quarter.

Analysis

Omnicell (OMCL) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

On a TTM basis, Omnicell's Net Income towards Common Stockholders came in at $44.67 million as of Sep 30, 2026, up 124.2% year-over-year; for FY2025, it was $2.05 million, down 83.6% from FY2024.

  • Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of -42.3% (FY2020 to FY2025).
  • Across earlier years, Net Income towards Common Stockholders came in at $12.53 million in FY2024, -$20.37 million in FY2023, $5.65 million in FY2022 (-92.7%) and $77.85 million in FY2021 (+141.8%).
  • Quarterly Net Income towards Common Stockholders has ranged from -$28.41 million in Q4 2022 to $24.29 million in Q2 2026 over the past five years.
  • On a year-over-year basis, Net Income towards Common Stockholders rose in three of the last four quarters, with growth averaging 111.8%.
  • Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 330.7% in Q2 2026, against a decline of 66.9% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $24.29 million (Q2 2026), $11.36 million (Q1 2026) and -$2.03 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 258.63 Bn 235.14 Bn 5.13 Bn 1.72 Bn
2 Abbott Laboratories 189.68 Bn 163.54 Bn 7.39 Bn 920.00 Mn
3 Danaher 162.39 Bn 142.05 Bn 3.84 Bn 1.24 Bn
4 Intuitive Surgical 159.59 Bn 139.88 Bn 2.08 Bn 522.80 Mn
5 Medtronic 130.39 Bn 95.64 Bn 6.34 Bn 1.47 Bn
6 Stryker 125.23 Bn 111.41 Bn 4.25 Bn 753.00 Mn
7 Boston Scientific 63.26 Bn 58.70 Bn 3.43 Bn 582.00 Mn
8 Edwards Lifesciences 59.81 Bn 43.02 Bn 1.35 Bn 307.50 Mn
9 Becton Dickinson 58.37 Bn 55.52 Bn 2.32 Bn 377.00 Mn
10 Omnicell 1.74 Bn 699.03 Mn 137.83 Mn 11.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.04 Mn
Jun 30, 2026 24.29 Mn
Mar 31, 2026 11.36 Mn
Dec 31, 2025 -2.03 Mn
Sep 30, 2025 5.46 Mn
Jun 30, 2025 5.64 Mn
Mar 31, 2025 -7.02 Mn
Dec 31, 2024 15.84 Mn
Sep 30, 2024 8.63 Mn
Jun 30, 2024 3.74 Mn
Mar 31, 2024 -15.68 Mn
Dec 31, 2023 -14.38 Mn
Sep 30, 2023 5.55 Mn
Jun 30, 2023 3.45 Mn
Mar 31, 2023 -15.00 Mn
Dec 31, 2022 -28.41 Mn
Sep 30, 2022 16.77 Mn
Jun 30, 2022 9.07 Mn
Mar 31, 2022 8.21 Mn
Dec 31, 2021 13.98 Mn
API Access

Omnicell Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=OMCL&period=max&api_key=YOUR_API_KEY